Jack Lazar Sells 2,500 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Jack Lazar sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $130.00, for a total value of $325,000.00. Following the transaction, the director owned 84,851 shares in the company, valued at approximately $11,030,630. The trade was a 2.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Astera Labs Stock Performance

Shares of ALAB stock opened at $126.34 on Thursday. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The stock has a 50 day moving average price of $145.64 and a two-hundred day moving average price of $166.93. The company has a market capitalization of $21.50 billion, a P/E ratio of 103.56, a PEG ratio of 2.51 and a beta of 1.74.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.07. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter last year, the business earned $0.37 earnings per share. The business’s revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, equities analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Royal Bank of Canada raised its holdings in Astera Labs by 167.3% in the 1st quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares in the last quarter. AQR Capital Management LLC boosted its stake in shares of Astera Labs by 213.4% during the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after purchasing an additional 7,756 shares in the last quarter. Empowered Funds LLC increased its position in shares of Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares during the period. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Astera Labs during the second quarter valued at about $615,000. Finally, Allworth Financial LP raised its stake in Astera Labs by 87.4% in the second quarter. Allworth Financial LP now owns 2,612 shares of the company’s stock worth $236,000 after buying an additional 1,218 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ALAB. Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Northland Securities upped their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a research note on Tuesday, December 9th. Weiss Ratings lowered shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Citigroup cut their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, February 11th. Finally, Royal Bank Of Canada initiated coverage on Astera Labs in a research report on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target for the company. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $202.22.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.